Policy Summit

Special Podcast Episode: Fifth Annual Policy Summit Highlights with Emily Walsh, PhD

Watch on demand through Oct. 23 | September 25, 2023

Emily Walsh, PhD, principal at Tremont Therapeutics Consulting, discussed what happened at this year’s Policy Summit—and why it was a big deal. Chris Leidli, member of ASGCT’s Communications Committee, hosted. Register for the Policy Summit today to watch sessions on demand until Oct. 23!

Policy Summit

Read Full Story

Watch the Policy Summit On Demand Through Oct. 23

Register Now | September 21, 2023

ASGCT's Policy Summit connects you with policy and industry leaders in the field where you'll learn from a variety of stakeholder perspectives and how they inform regulatory, legislative, and payment policies that impact gene and cell therapy development.

Policy Summit

Read Full Story

Hear from Congressmen Scott Peters + Brett Guthrie

Don't Miss: Sept. 18-19! | September 12, 2023

Reps. Peters and Guthrie will make opening remarks for in-person attendees at the Policy Summit Networking Reception. Register today to be part of this and more events with top CGT decision makers, Sept. 18-19 (virtually + in-person)! 

Policy Summit

Read Full Story

Why Anyone in CGT Can Benefit from ASGCT’s Policy Summit

Podcast With Francesca Cook | September 08, 2023

Francesca Cook, past chair of ASGCT's Government Relations Committee, discussed the annual conference from its inception—and why anyone in CGT should join. Plus, hear her advice for making the best of it. Chris Leidli, member of ASGCT’s Communications Committee, hosted this episode for his Rx for Biotech podcast and the Society’s Podcast Network.

Policy Summit

Read Full Story

Featured at the Policy Summit: The Future of CGT Manufacturing

Discuss Sept. 18-19 | September 08, 2023

The future of CGT access lies in efficient development and manufacturing—here's how regulatory bodies like the FDA are tackling the relevant challenges. Register today to be part of this and more discussions with top CGT decision makers, Sept. 18-19 (virtually + in-person in Washington, DC)! 

Policy Summit

Read Full Story

Explore Patient-Focused Development at the Policy Summit

Join experts + advocates Sept. 18-19 | August 31, 2023

Discuss patient access challenges in the U.S. health system and how to incorporate patient perspectives and the principles of Patient-focused Drug Development (PFDD). Register today to be part of this and more discussions with top CGT decision makers, Sept. 18-19 (virtually + in-person)! 

Policy Summit

Read Full Story

Discuss CGT Access with Laura McWright at the Policy Summit

Connect Sept. 18-19 | August 28, 2023

Laura McWright, Deputy Director of the Seamless Care Models Group at the Centers for Medicaid and Medicare Innovation (CMMI), will discuss CMMI’s Cell & Gene Therapy Access Model at the Policy Summit. Register today to be part of this and more discussions with top CGT decision makers, Sept. 18-19 (virtually + in-person)! 

Policy Summit

Read Full Story

Join a Fireside Chat with Dr. Renee Wegrzyn, Director of ARPA-H, at the Policy Summit

Register for Sept. 18-19 | August 24, 2023

Dr. Wegrzyn will talk about the role of the Advanced Research Projects Agency for Health (ARPA-H) in supporting innovative science, with time to ask questions. Register today to be part of this and more discussions with top CGT decision makers, Sept. 18-19 (virtually + in-person)! 

Policy Summit

Read Full Story

Meet Dr. Nicole Verdun, New Director of FDA CBER OTP, at the Policy Summit

Join Sept. 18-19 | August 21, 2023

Dr. Verdun will talk about the new super office at FDA CBER, with time to ask questions. Register today to be part of this and more discussions with top CGT decision makers, Sept. 18-19 (virtually + in-person)! 

Policy Summit

Read Full Story

Why You Should Apply for the Congressional Policy Fellowship

Diane Berry, PhD | August 21, 2023

Dr. Berry explains why ASGCT members should apply for a unique opportunity to explore the intersection of science and policy.

Policy Summit

Read Full Story

Policy Summit Speakers Explore Boundless Opportunities, Significant Challenges

Chiagbanwe (ChiChi) Enwere, MPH | October 13, 2022

The need for proactive communication was repeatedly stressed during the fourth annual Policy Summit. Speakers said this could decrease issues that might otherwise stall development or impede access.

Policy Summit

Read Full Story

Policy Summit Speakers Offer Strategies to Deal With the Challenges of Accelerated Approval

ASGCT Staff | October 06, 2021

FDA's accelerated approval program allows for early approval of drugs and biologics that treat serious conditions with a lack of alternate treatments.

Policy Summit

Read Full Story

Engage Patients Early to Ensure Successful Therapeutics

Rachel Salzman, DVM | October 05, 2021

Increasing patient input will contribute to developing and delivering transformative medicines to benefit all of society, says Rachel Salzman, DVM.

Policy Summit

Read Full Story

Policy Summit Takeaways Include Advice for Action on Access

ASGCT Staff | September 27, 2021

During sessions on Medicare and Medicaid payment policies, speakers on the first day of the Policy Summit provided potential solutions for stakeholders working toward patient access to gene and cell therapies.

Policy Summit

Read Full Story

A Call to Arms: Transparency and Inclusion in Gene and Cell Therapy Development

Emily Walsh Martin, PhD | September 24, 2021

It is more important than ever that the field continues transparent data sharing and collaborative solution finding to meet the challenges we will continue to discover in the clinic, says Emily Walsh Martin, PhD.

Policy Summit

Read Full Story

Considering Payors on the Path to Patient Access

Emily Walsh Martin, PhD | September 23, 2021

The sessions on the first day of the Policy Summit will provide you with a deeper understanding of the questions, complexities, and solution options at play for patient access to the therapies you are developing.

Policy Summit

Read Full Story